Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
Healthcare (Amsterdam, Netherlands)|September 18, 2016
Impact of provider mailings on medication adherence by Medicare Part D membersBijan J Borah, Yang Qiu, Nilay D Shah, et al.Journal of Managed Care & Specialty Pharmacy|July 31, 2023
Descriptive, real-world treatment patterns, resource use, and total cost of care among eculizumab- and ravulizumab-treated members with paroxysmal nocturnal hemoglobinuriaKelly C Broderick, James P Burke, Jesse Fishman, et al.Pharmacotherapy|July 12, 2005
Medical and pharmacy expenditures after implementation of a cyclooxygenase-2 inhibitor prior authorization programPatrick P Gleason, Clint Williams, Sally Hrdy, et al.Journal of Managed Care & Specialty Pharmacy|September 18, 2025
AMCP real-world evidence standards: Overcoming barriers to using real-world evidence in US payer decision-makingCatherine M Lockhart, Elizabeth Powers, Brian Sweet, et al.Journal of the American Geriatrics Society|August 12, 2011
Exposure to potentially harmful drug-disease interactions in older community-dwelling veterans based on the Healthcare Effectiveness Data and Information Set quality measure: who is at risk?Mary Jo V Pugh, Catherine I Starner, Megan E Amuan, et al.Journal of Managed Care & Specialty Pharmacy|February 27, 2026
Trends in 1-year persistence and adherence among initiators of high-potency, weight loss-indicated glucagon-like peptide 1 receptor agonistsLandon Z Marshall, Patrick P Gleason, Nicholas Friedlander, et al.Pharmacoepidemiology and Drug Safety|July 25, 2013
Impact of a drug utilization review program on high-risk use of prescription controlled substancesMatthew Daubresse, Patrick P Gleason, Yi Peng, et al.Journal of Managed Care & Specialty Pharmacy|May 8, 2024
Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetesPatrick P Gleason, Benjamin Y Urick, Landon Z Marshall, et al.Journal of Managed Care Pharmacy : JMCP|December 8, 2007
Utilization, cost trends, and member cost-share for self-injectable multiple sclerosis drugs--pharmacy and medical benefit spending from 2004 through 2007April M Kunze, Brent W Gunderson, Patrick P Gleason, et al.Journal of Managed Care & Specialty Pharmacy|March 11, 2020
Medical Costs and Health Care Utilization Among Self-Insured Members with Carve-In Versus Carve-Out Pharmacy BenefitsJulia J Smith, Yang Qiu, Steve V Lam, et al.Pageof 4